Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: Short-term efficacy and adverse effects

Archives of General Psychiatry

Volumn 66, Issue 7, 2009, Pages 729-737

  Sackeim, Harold A ^a,b,g   Dillingham, Elaine M ^a,b   Prudic, Joan ^a,b   Cooper, Thomas ^a,b   McCall, W Vaughn ^c   Rosenquist, Peter ^c   Isenberg, Keith ^d   Garcia, Keith ^d   Mulsant, Benoit H ^e,f   Haskett, Roger F ^e  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LORAZEPAM; NORTRIPTYLINE; PLACEBO; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DRUG BLOOD LEVEL; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; EVENING DOSAGE; FEMALE; HAMILTON SCALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SUICIDE ATTEMPT; TACHYCARDIA; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NORTRIPTYLINE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67650446544     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2009.75     Document Type: Article

References (47)

1. American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. 2nd ed. Washington, DC: American Psychiatric Press; 2001.
2. Kalinowsky LB, Hoch PH. Shock Treatments and Other Somatic Procedures in Psychiatry. New York, NY: Grune & Stratton; 1946.
3. Hamilton M. The effect of treatment on the melancholias (depressions). Br J Psychiatry. 1982;140:223-230.
4. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004;55(3):301-312.
5. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328(12):839-846.
6. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57(5):425-434.
7. Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O'Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63(12):1337-1344.
8. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990;31(3):287-296.
9. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10(2):96-104.
10. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153(8):985-992.
11. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917.
12. Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007;164(2):201-204.
13. Sackeim HA, Brannan SK, Rush AJ, George MS, Marangell LB, Allen J. Durability of antidepressant response to vagus nerve stimulation (VNS) [published online ahead of print February 9, 2007]. Int J Neuropsychopharmacol. 2007;10(6):817-826.
14. Dunlop E. Combination of antidepressants with electroshock therapy. Dis Nerv Syst. 1960;21:513-514.
15. Ravn J. A comparison of past and present treatments of endogenous depression. Br J Psychiatry. 1966;112:501-504.
16. Kay D, Fahy T, Garside R. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry. 1970;117(541):667-671.
17. Muller D. 1. Nardil (phenelzine) as a potentiator of electroconvulsive therapy (ECT): 2. a survey of out-patient ECT. J Ment Sci. 1961;107:994-996.
18. Seager CP, Bird RL. Imipramine with electrical treatment in depression: a controlled trial. J Ment Sci. 1962;108:704-707.
19. Imlah NW, Ryan E, Harrington JA. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology. 1965;4:438-442.
20. Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand. 1996;94(4):241-251.
21. Ellis P; Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry. 2004;38(6):389-407.
22. Scott AIF. Psychotropic drug treatment during and after ECT. In: Scott AIF, ed. The ECT handbook. 2nd ed. London, England: Royal College of Psychiatrists; 2005:109-116.
23. Sackeim HA. Continuation therapy following ECT: directions for future research. Psychopharmacol Bull. 1994;30(3):501-521.
24. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285(10):1299-1307.
25. Navarro V, Gasto C, Torres X, Masana G, Penades R, Guarch J, Vazquez M, Serra M, Pujol N, Pintor L, Catalan R. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. Am J Geriatr Psychiatry. 2008;16(6):498-505.
26. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry. 1987;144(11):1449-1455.
27. McCall WV, Reboussin DM, Weiner RD, Sackeim HA. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry. 2000;57(5):438-444.
28. McCall WV, Dunn A, Rosenquist PB, Hughes D. Markedly suprathreshold right unilateral ECT versus minimally suprathreshold bilateral ECT: antidepressant and memory effects. J ECT. 2002;18(3):126-129.
29. Prudic J, Olfson M, Sackeim HA. Electro-convulsive therapy practices in the community. Psychol Med. 2001;31(5):929-934.
30. Sackeim HA, Prudic J, Fuller RB, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32(1):244-254.
31. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition (with Psychotic Screen) (SCID-I/P). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
33. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
34. Sackeim H, Decina P, Prohovnik I, Malitz S. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry. 1987;44(4):355-360.
35. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):10-17.
36. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: Superintendent of Documents, US Government Printing Office, US Department of Health, Education, and Welfare; 1976. Publication No. 76-338.
37. Beck AT, Steer RA, Brown GK. Beck Depression Inventory Manual. 2nd ed. San Antonio, TX: Psychological Corporation; 1996.
38. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1-100.
39. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment, and Parkinson's disease. Neurology. 1981;31(6):645-650.
40. Baddeley A. Working Memory. Oxford, England: Clarendon; 1986.
41. Buschke H. Selective reminding for analysis of memory and learning. J Verbal Learning Verbal Behav. 1973;12:543-550.
42. McElhiney MC, Moody BJ, Steif BL, Prudic J, Devanand DP, Nobler MS, Sackeim HA. Autobiographical memory and mood: effects of electroconvulsive therapy. Neuropsychology. 1995;9:501-517.
43. Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry. 1987;22(3):249-268.
44. Sackeim HA, Long J, Luber B, Moeller JR, Prohovnik I, Devanand DP, Nobler MS. Physical properties and quantification of the ECT stimulus I: basic principles. Convuls Ther. 1994;10(2):93-123.
45. McGaugh JL, Petrinovich LF. Neural consolidation and electroconvulsive shock reexamined. Psychol Rev. 1966;73(4):382-387.
46. Kety S. Biochemical and neurochemical effects of electroconvulsive shock. In: Fink M, Kety S, McGaugh J, Williams T, eds. Psychobiology of Convulsive Therapy. Washington, DC: VH Winston & Sons; 1974:285-294.
47. Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, Berman RM, Brakemeier EL, Perera T, Devanand DP. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulation. 2008;1(2):71-83.